Biomea Fusion 株価情報 (NASDAQ: BMEA)

最新ニュース Biomea Fusion (NASDAQ:BMEA) 株価情報

BIOMEA FUSION INC

Biomea Fusion

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.

Biomea Fusion Inc

<h3>Gainers</h3>
<ul>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares increased by 13.6% to $0.29 during Friday's after-market session. The company's market cap stands at $32.0 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) shares rose 12.23% to $1.19. The company's market cap stands at $16.3 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares moved upwards by 11.99% to $2.8. The company's market cap stands at $7.0 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock increased by 9.99% to $1.98. The market value of their outstanding shares is at $38.9 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares increased by 7.71% to $6.0. The company's market cap stands at $140.6 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) shares moved upwards by 7.17% to $0.89. The market value of their outstanding shares is at $17.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) stock fell 26.2% to $5.06 during Friday's after-market session. The market value of their outstanding shares is at $111.5 million. As per the press release, Q1 earnings came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock decreased by 11.19% to $1.35. The company's market cap stands at $22.1 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) stock fell 10.21% to $2.2. The company's market cap stands at $6.7 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAT#NASDAQ">FAT</a>) shares fell 9.99% to $2.24. The market value of their outstanding shares is at $39.8 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSA#NASDAQ">VSA</a>) shares fell 9.67% to $0.93. The market value of their outstanding shares is at $9.2 million. </li>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) stock decreased by 9.13% to $0.35. The company's market cap stands at $7.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

GORV

NAAS

PLCE

RIME

YSXT

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares rose 8.2% to $14.61 during Friday's after-market session. The market value of their outstanding shares is at $211.8 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares rose 6.67% to $0.43. The company's market cap stands at $1.8 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock rose 6.66% to $3.2. The market value of their outstanding shares is at $5.2 million. </li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock rose 6.38% to $1.64. The market value of their outstanding shares is at $27.8 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares increased by 6.25% to $0.82. The company's market cap stands at $27.1 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) stock rose 6.24% to $0.85. The market value of their outstanding shares is at $23.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 22.2% to $4.18 during Friday's after-market session. The company's market cap stands at $2.1 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock decreased by 9.93% to $2.45. The market value of their outstanding shares is at $6.3 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) stock decreased by 9.81% to $0.46. The company's market cap stands at $9.4 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock declined by 9.58% to $22.0. The market value of their outstanding shares is at $572.3 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares decreased by 8.32% to $1.43. The company's market cap stands at $10.7 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares fell 7.48% to $3.96. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABVC

APDN

FEMY

GTBP

JUNS

LIMN

NUWE

OGEN

PTHL

TCRT

TLPH

12 Health Care Stocks Moving In Friday's After-Market Session

News

Offerings

Bowhead Specialty Files For Mixed Shelf Of Up To $300M

<h3>Gainers</h3>
<ul>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) shares rose 34.0% to $0.35 during Friday's after-market session. The company's market cap stands at $19.3 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock rose 9.47% to $0.44. The market value of their outstanding shares is at $63.3 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock rose 8.78% to $2.6. The company's market cap stands at $50.1 million. </li>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) stock rose 6.5% to $5.73. The company's market cap stands at $484.4 million. </li>
<li>Archer Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) shares rose 6.47% to $10.85. The market value of their outstanding shares is at $5.9 billion. </li>
<li>Cycurion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) stock moved upwards by 5.76% to $0.43. The company's market cap stands at $13.6 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Armlogi Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>) stock decreased by 13.2% to $1.12 during Friday's after-market session. The company's market cap stands at $47.1 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares fell 8.38% to $3.49. The company's market cap stands at $9.4 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 7.29% to $0.27. The company's market cap stands at $61.7 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 5.01% to $0.43. The market value of their outstanding shares is at $7.8 million. </li>
<li>Nixxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) stock declined by 4.77% to $2.2. The company's market cap stands at $42.1 million. </li>
<li>ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) shares fell 4.45% to $4.73. The company's market cap stands at $290.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHR

BTOC

CYCU

EVTL

ILAG

LNZA

Nuveen Insured California Premium Fund Ii

NIXX

SCWO

SRFM

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 11.3% to $0.73 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) stock rose 8.33% to $79.0. The market value of their outstanding shares is at $11.9 billion. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) stock increased by 6.15% to $1.7. The market value of their outstanding shares is at $35.7 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) shares moved upwards by 5.8% to $0.42. The company's market cap stands at $11.0 million. </li>
<li>Forward Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORD#NASDAQ">FORD</a>) stock rose 4.92% to $6.82. The market value of their outstanding shares is at $7.5 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock increased by 3.47% to $2.68. The market value of their outstanding shares is at $56.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) stock decreased by 6.3% to $3.29 during Friday's after-market session. The market value of their outstanding shares is at $32.1 million. </li>
<li>SiTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SITM#NASDAQ">SITM</a>) stock fell 5.0% to $195.55. The company's market cap stands at $4.6 billion. </li>
<li>Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) shares fell 4.55% to $8.2. The company's market cap stands at $95.5 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock decreased by 4.17% to $1.15. The company's market cap stands at $5.8 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares decreased by 4.11% to $3.5. The company's market cap stands at $5.3 million. </li>
<li>BIO-key International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares fell 4.08% to $0.82. The company's market cap stands at $4.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKYI

BTCS

CLRO

DUOT

ENTG

FORD

MOVE

PRSO

SITM

SOBR

VRAR

12 Information Technology Stocks Moving In Friday's After-Market Session

Management

Oceaneering International Vice President And CFO Alan R. Curtis To Retire From His Position Effective January 1, 2026.

General

374water Files Prospectus Relating To Sale Of Up To $100M Shares Of Common Stock From Time To Time

In the current session, the stock is trading at $417.92, after a 0.43% spike. Over the past month, Motorola Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) stock increased by 2.81%, and in the past year, by 11.80%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1749243635_0.png" alt="Past Year Chart" />

<h3>Comparing Motorola Solutions P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 84.77 in the Communications Equipment industry, Motorola Solutions Inc. has a lower P/E ratio of 34.71. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749243635_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

A Look Into Motorola Solutions Inc's Price Over Earnings

Prestige Consumer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBH#NYSE">PBH</a>) has outperformed the market over the past 15 years by 5.46% on an annualized basis producing an average annual return of 17.46%. Currently, Prestige Consumer has a market capitalization of $4.20 billion. 
Buying $1000 In PBH: If an investor had bought $1000 of PBH stock 15 years ago, it would be worth $11,018.13 today based on a price of $85.06 for PBH at the time of writing.
<h3>Prestige Consumer's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749243626_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

AMZE

Amaze Holdings To Offer & Sell Up To 44.6M Shares Of Common Stock By Selling Stockholder

WIIM

NCL stock has given up its prior gain. Northann shares were trading higher amid ongoing volatility. The company announced  that it is not aware of any new material developments or pending announcements concerning its business operations that may be contributing to the recent volatile market activity.

OACC

Oaktree Acquisition Corp. III Life Sciences CFO Courtney Conigliaro Resigned On June 3, 2025;  Thomas Sweeney Named As New Chief Financial Officer Effective Immediately

BBAI

BigBear.ai Names Sean Ricker Interim Chief Financial Officer, Effective Immediately

TIVC

Tivic Health Systems Inc Files For Resale Of 8.4M Shares Of Common Stock By Selling Stockholder

On June 6, 2025, Nektar Therapeutics (the "Company") filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Increase in Authorized Shares Amendment") with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company's common stock, par value $0.0001 (the "Common Stock"), from 300,000,000 shares to 390,000,000 shares. The Increase in Authorized Shares Amendment was previously approved by the Company's stockholders at the Annual Meeting of Stockholders held on May 23, 2025 and became effective upon its filing.
&nbsp;
A copy of the Increase in Authorized Shares Amendment is filed as Exhibit 3.1 hereto and is incorporated herein by reference.
&nbsp;
On June 6, 2025, the Company also filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Reverse Stock Split Amendment") with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company's Common Stock at a ratio of one-for-fifteen (the "Reverse Stock Split"). The Reverse Stock Split Amendment provides that the Reverse Stock Split will become effective as of 11:59 p.m. Eastern Time on June 8, 2025 (the "Effective Time"), at which time every fifteen shares of the Company's Common Stock issued and outstanding immediately prior to the Effective Time will be automatically combined into one share of Common Stock. No fractional shares of Common Stock will be issued as a result of the Reverse Stock Split. Instead, any fractional shares resulting from the Reverse Stock Split will be rounded up at the participant level with The Depository Trust Company, if such shares of Common Stock are held directly or rounded down to the nearest whole share of Common Stock, if such shares are subject to an award granted under the 2017 Amended and Restated Performance Incentive Plan.
&nbsp;
Trading of the Company's common stock on a split-adjusted basis will begin at market open on June 9, 2025 under the existing symbol "NKTR" and new CUSIP number 640268306. The Reverse Stock Split will not change the number of authorized shares of the Company's Common Stock, which will remain at 390,000,000 shares following effect of the Increase in Authorized Shares Amendment.
&nbsp;
A copy of the Reverse Stock Split Amendment is filed as Exhibit 3.2 hereto and is incorporated herein by reference.

Stock Split

NKTR

Nektar Therapeutics Files Amendments To Increase Authorized Common Stock From 300M To 390M Shares And Implement 1-For-15 Reverse Stock Split Effective June 8, 2025; Split-Adjusted Trading To Begin June 9, 2025

Guidance

Children's Place Says Results Remain Under Pressure Due To Current Macroeconomic Environment;For Fiscal 2025, We Expect To See Continued Top-line Sales Pressures

BRZE

Braze Files For Resale Of $3.9M Shares Of Class A Common Stock By Selling Stockholders

NOTE

FiscalNote Holdings Files For Offering Of Up To 12.5M Class A Common Stock By Selling Stockholder

LVWR

Livewire Group Tralisa Maraj Resigns As CFO Effective July 11, 2025

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm" title="https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm</a>

Pimco Announces $1B Offering

Health Care

Press Releases

Biomea Fusion to Become a Diabetes & Obesity Medicines Company

Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes

Biomea Fusion, Inc. Reports Inducement Grant under  Nasdaq Listing Rule 5635(c)(4)

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

Biomea Fusion Announces Leadership Transition

Earnings

Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights

Biomea Fusion's BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia

Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

Comments

Biomea Fusion

ニュース

最新ニュース Biomea Fusion (NASDAQ:BMEA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル